127 related articles for article (PubMed ID: 38474631)
21. Design, Synthesis, and Anti-Cancer Evaluation of Novel Water-Soluble Copper(I) Complexes Bearing Terpyridine and PTA Ligands.
Smoleński P; Śliwińska-Hill U; Kwiecień A; Wolińska J; Poradowski D
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474457
[TBL] [Abstract][Full Text] [Related]
22. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract][Full Text] [Related]
23. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
Matesanz AI; Leitao I; Souza P
J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
[TBL] [Abstract][Full Text] [Related]
24.
Bouché M; Vincent B; Achard T; Bellemin-Laponnaz S
Molecules; 2020 Jul; 25(14):. PubMed ID: 32660104
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferative activity and DNA binding studies of cyclometalated complexes of platinum(II) containing 2-vinylpyridine.
Mojaddami A; Karimi A; Mahdavinia M; Fereidoonnezhad M
Biometals; 2022 Jun; 35(3):617-627. PubMed ID: 35445906
[TBL] [Abstract][Full Text] [Related]
26. Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance Mechanisms.
Hildebrandt J; Häfner N; Kritsch D; Görls H; Dürst M; Runnebaum IB; Weigand W
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563367
[TBL] [Abstract][Full Text] [Related]
27. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation.
Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA
Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661
[TBL] [Abstract][Full Text] [Related]
28. Piano-stool ruthenium(II) complexes with maleimide and phosphine or phosphite ligands: synthesis and activity against normal and cancer cells.
Juszczak M; Das S; Kosińska A; Rybarczyk-Pirek AJ; Wzgarda-Raj K; Tokarz P; Vasudevan S; Chworos A; Woźniak K; Rudolf B
Dalton Trans; 2023 Mar; 52(13):4237-4250. PubMed ID: 36897334
[TBL] [Abstract][Full Text] [Related]
29. New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules.
Savić A; Marzo T; Scaletti F; Massai L; Bartoli G; Hoogenboom R; Messori L; Van Deun R; Van Hecke K
Biometals; 2019 Feb; 32(1):33-47. PubMed ID: 30367340
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
Vrzal R; Starha P; Dvorák Z; Trávnícek Z
J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
[TBL] [Abstract][Full Text] [Related]
31. Dinuclear gold(I) complexes with
Trevisan G; Vitali V; Tubaro C; Graiff C; Marchenko A; Koidan G; Hurieva AN; Kostyuk A; Mauceri M; Rizzolio F; Accorsi G; Biffis A
Dalton Trans; 2021 Oct; 50(38):13554-13560. PubMed ID: 34505859
[TBL] [Abstract][Full Text] [Related]
32. Platinum(II) carboxylato complexes containing 7-azaindoles as N-donor carrier ligands showed cytotoxicity against cancer cell lines.
Štarha P; Trávníček Z; Pazderová L; Dvořák Z
J Inorg Biochem; 2016 Sep; 162():109-116. PubMed ID: 27350081
[TBL] [Abstract][Full Text] [Related]
33. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
[TBL] [Abstract][Full Text] [Related]
34. Coordination environment dependence of anticancer activity in cyclometalated bismuth(III) complexes with C,O-chelating ligands.
Lei J; Liu Y; Yin M; Li S; Wang Z; Chen Y
J Inorg Biochem; 2024 Jul; 256():112571. PubMed ID: 38669912
[TBL] [Abstract][Full Text] [Related]
35. Lipophilicity-dependent ruthenium N-heterocyclic carbene complexes as potential anticancer agents.
Lv G; Guo L; Qiu L; Yang H; Wang T; Liu H; Lin J
Dalton Trans; 2015 Apr; 44(16):7324-31. PubMed ID: 25797411
[TBL] [Abstract][Full Text] [Related]
36. Quinolyl-Based PGM Metallarectangles: Antiproliferative Activity, DNA and BSA Protein Interactions, and a Molecular Docking Perspective.
Golding TM; Omondi RO; Biswas S; Chakraborty S; Prince S; Smith GS
Chembiochem; 2023 Jul; 24(13):e202300271. PubMed ID: 37191065
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro anticancer activities of selenium N-heterocyclic carbene compounds.
Huang S; Sheng X; Bian M; Yang Z; Lu Y; Liu W
Chem Biol Drug Des; 2021 Sep; 98(3):435-444. PubMed ID: 34051050
[TBL] [Abstract][Full Text] [Related]
38. Enhanced cytotoxicity of silver complexes bearing bidentate N-heterocyclic carbene ligands.
Monteiro DC; Phillips RM; Crossley BD; Fielden J; Willans CE
Dalton Trans; 2012 Apr; 41(13):3720-5. PubMed ID: 22327273
[TBL] [Abstract][Full Text] [Related]
39. Green synthesis of selenium based N-heterocyclic carbene compounds; structural, in-vitro anticancer and molecular docking studies.
Hayat K; Tariq U; Wong QA; Quah CK; Majid ASA; Nazari V M; Ahamed MBK; Iqbal MA; Tirmizi SA
Comput Biol Chem; 2021 Oct; 94():107567. PubMed ID: 34500323
[TBL] [Abstract][Full Text] [Related]
40. Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium.
Zou T; Lok CN; Wan PK; Zhang ZF; Fung SK; Che CM
Curr Opin Chem Biol; 2018 Apr; 43():30-36. PubMed ID: 29136524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
